227 related articles for article (PubMed ID: 32677888)
21. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
Tribuddharat C; Moore RA; Baker P; Woods DE
Antimicrob Agents Chemother; 2003 Jul; 47(7):2082-7. PubMed ID: 12821450
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
Dutta S; Haq S; Hasan MR; Haq JA
BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
[TBL] [Abstract][Full Text] [Related]
23. Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.
Sam IC; See KH; Puthucheary SD
J Clin Microbiol; 2009 May; 47(5):1556-8. PubMed ID: 19297597
[TBL] [Abstract][Full Text] [Related]
24. Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.
Dalhoff A; Nasu T; Okamoto K
Chemotherapy; 2003 Jul; 49(4):172-83. PubMed ID: 12886052
[TBL] [Abstract][Full Text] [Related]
25. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
[TBL] [Abstract][Full Text] [Related]
26. Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in Streptococcus pneumoniae.
Li Y; Metcalf BJ; Chochua S; Li Z; Gertz RE; Walker H; Hawkins PA; Tran T; Whitney CG; McGee L; Beall BW
mBio; 2016 Jun; 7(3):. PubMed ID: 27302760
[TBL] [Abstract][Full Text] [Related]
27. Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
Sarovich DS; Price EP; Limmathurotsakul D; Cook JM; Von Schulze AT; Wolken SR; Keim P; Peacock SJ; Pearson T
Infect Drug Resist; 2012; 5():129-32. PubMed ID: 22977307
[TBL] [Abstract][Full Text] [Related]
28. Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments.
Chen K; Sun GW; Chua KL; Gan YH
Antimicrob Agents Chemother; 2005 Mar; 49(3):1002-9. PubMed ID: 15728895
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
30. Drug susceptibility and biofilm formation of Burkholderia pseudomallei in nutrient-limited condition.
Anutrakunchai C; Sermswan RW; Wongratanacheewin S; Puknun A; Taweechaisupapong S
Trop Biomed; 2015 Jun; 32(2):300-9. PubMed ID: 26691259
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.
Chantratita N; Rholl DA; Sim B; Wuthiekanun V; Limmathurotsakul D; Amornchai P; Thanwisai A; Chua HH; Ooi WF; Holden MT; Day NP; Tan P; Schweizer HP; Peacock SJ
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17165-70. PubMed ID: 21969582
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.
Chirakul S; Norris MH; Pagdepanichkit S; Somprasong N; Randall LB; Shirley JF; Borlee BR; Lomovskaya O; Tuanyok A; Schweizer HP
Sci Rep; 2018 Jul; 8(1):10652. PubMed ID: 30006637
[TBL] [Abstract][Full Text] [Related]
33. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
Gunkel AG; Hechler U; Martin HH
J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
[TBL] [Abstract][Full Text] [Related]
34. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase.
Godfrey AJ; Wong S; Dance DA; Chaowagul W; Bryan LE
Antimicrob Agents Chemother; 1991 Aug; 35(8):1635-40. PubMed ID: 1718214
[TBL] [Abstract][Full Text] [Related]
36. D-LL-31 in combination with ceftazidime synergistically enhances bactericidal activity and biofilm destruction in
Wongkaewkhiaw S; Taweechaisupapong S; Anutrakunchai C; Nazmi K; Bolscher JGM; Wongratanacheewin S; Kanthawong S
Biofouling; 2019 May; 35(5):573-584. PubMed ID: 31282211
[TBL] [Abstract][Full Text] [Related]
37. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps.
Sirijant N; Sermswan RW; Wongratanacheewin S
J Med Microbiol; 2016 Nov; 65(11):1296-1306. PubMed ID: 27702426
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
39. Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of
Lonsway DR; Elrod MG; Kendrick N; Tiller R; Sullivan MM; Edwards JR; Blaney DD; Karlsson M
Microb Drug Resist; 2020 Apr; 26(4):311-318. PubMed ID: 31596673
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
Maloney S; Engler C; Norton R
J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
